COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer.

Cong Zeng John P Evans Karthik Chakravarthy Panke Qu Sarah Reisinger No-Joon Song Mark P Rubinstein Peter G Shields Zihai Li Shan-Lu Liu

Cancer Cell

Center for Retrovirus Research, Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, USA; Viruses and Emerging Pathogens Program, Infectious Diseases Institute, Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, Ohio State University, Columbus, OH 43210, USA. Electronic address:

Published: February 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716174	PMC
http://dx.doi.org/10.1016/j.ccell.2021.12.014	DOI Listing

Publication Analysis

Top Keywords

covid-19 mrna

mrna booster

booster vaccines

vaccines elicit

elicit strong

strong protection

protection sars-cov-2

sars-cov-2 omicron

omicron variant

variant patients

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!